Let's Talk Medtech with PwC's Glenn Hunzinger

PwC's Glenn Hunzinger stops by to discuss the  Pharmaceutical and life sciences deals insights: 2021 midyear outlook report, showcasing the PLS sector returned to normal deal activity with strong deal volume. Plus, Omar Ford, MD+DI's Managing Editor gives his take on the controversial Illumina/Grail merger.

NOW PLAYING

0:00 24:26

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

🚨SUNO Flips on Artist - Creators, this matters. 🎵🤖

Feb 8, 2026 ·4m

Mastering AI & Prompting

Jan 30, 2026 ·6m

The AI Realtor Prompt Vault

Dec 15, 2025 ·2m

🚨 AI NEWS ALERT — FAMILY, PAY ATTENTION! 🤖🔥 #aierik

Nov 30, 2025 ·5m

The Essential AI Awakening for Everyone

Oct 26, 2025 ·14m

🎙️ Missed Our First Podcast? #aierik #stayintunedpodcast

Oct 26, 2025 ·61m

Similar Podcasts

Humanizing Change Tremendousness Join us each episode as we talk with innovators in their respective fields about their unique journeys and how they humanize change in their own work, right here, on Humanizing Change. AI Erik's Podcast Audio Erik Conn The AI News Podcast where we talk AI. The PFN Cincinnati Bengals Podcast Pro Football Network The PFN Cincinnati Bengals Podcast is where you can stay up-to-date with the latest news and analysis on the Cincinnati Bengals! Our hosts, industry experts Jay Morrison and Dallas Robinson, provide weekly coverage of all the latest rumors and updates about the Bengals. Don’t forget to follow the show to receive new episodes directly in your podcast feed and leave a rating and review to let us know your thoughts. NEWMORROW SESSIONS - A PodCast Series on the Future of Hospitality Mario C. Bauer, Florian Schneider, Axel Weber & Dr. Tillman Bardt The Newmorrow PodCast is more than a podcast — it's a platform for open dialog on the future of our business, a platform for those building what doesn’t exist yet. Here, we share and embrace our passion for the hospitality industry, but we won’t romanticize the journey. We ask the tough questions, confront uncomfortable truths, and prepare for a future that resists easy answers. We believe that the tougher and wilder times become, the more openly, honestly and humanely people need to talk to each other and act together. We believe, openness, togetherness, and truthfulness should also be cornerstones of a professional community to develop our utopian idea of „open source“. This is a space where visionaries don’t just imagine the future — they wrestle with the paradoxes that shape it: success vs. happiness, data vs. instinct, stability vs. reinvention. Join leaders, entrepreneurs, and thinkers as they share not what made them — but what’s actively shaping them, now and next. So tune in

Frequently Asked Questions

How long is this episode of Let’s Talk Medtech?

This episode is 24 minutes long.

When was this Let’s Talk Medtech episode published?

This episode was published on August 26, 2021.

What is this episode about?

PwC's Glenn Hunzinger stops by to discuss the Pharmaceutical and life sciences deals insights: 2021 midyear outlook report, showcasing the PLS sector returned to normal deal activity with strong deal volume. Plus, Omar Ford, MD+DI's Managing Editor...

Can I download this Let’s Talk Medtech episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.

URL copied to clipboard!